Perceptive Advisors’s Relmada Therapeutics RLMD Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-2,383,478	Closed	-$88.2M	–	105
2022 Q3	$88.2M	Buy	2,383,478 +2,262,128	+1,864%	+$83.7M	2.56%	12
2022 Q2	$2.3M	Sell	121,350 -30,000	-20%	-$570K	0.07%	94
2022 Q1	$4.09M	Buy	+151,350	New	+$4.09M	0.08%	112